The pharmacist's role in teaching methotrexate injection for patients with Crohn's disease

American Journal of Health-System Pharmacy

Volumn 63, Issue 19, 2006, Pages 1792-1794

  Clark, Colleen A ^a   Mehta, Bella H ^a   Pruchnicki, Maria C ^a   Rodis, Jennifer L ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FOLIC ACID; METHOTREXATE; SODIUM CHLORIDE;

ANOREXIA; BLEEDING; BLOOD CELL COUNT; COUGHING; CREATININE BLOOD LEVEL; CROHN DISEASE; DIARRHEA; DRUG SELF ADMINISTRATION; DYSPNEA; FEVER; GASTROINTESTINAL SYMPTOM; HAIR LOSS; HOME CARE; HUMAN; LIVER FUNCTION TEST; MOUTH ULCER; NAUSEA; PATIENT EDUCATION; PATIENT REFERRAL; PHARMACIST; PHOTOSENSITIVITY; PRIORITY JOURNAL; RASH; REMISSION; SELF INJECTION; SHORT SURVEY; STOMATITIS; SYRINGE; THORAX RADIOGRAPHY; VOMITING;

EID: 33749250790     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060051     Document Type: Short Survey

References (13)

1. Crohn's & Colitis Foundation of America. About Crohn's disease and ulcerative colitis. www.ccfa.org/about/press/ibdfacts (accessed 2006 Jan 23).
2. Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2004; 53(suppl V):1-16.
3. Feagan BG, Rochon J, Fedorak RN et al. Methotrexate for the treatment of Crohn's disease. N Engl J Med. 1995; 332:292-7.
4. Feagan BG, Fedorak RN, Irvine EJ et al. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. N Engl J Med. 2000; 342:1627-32.
5. Arthur V, Jubb R, Homer D. A study of parenteral use of methotrexate in rheumatic conditions. J Clin Nurs. 2002; 11:256-63.
6. Livermore P. Teaching home administration of sub-cutaneous methotrexate. Paediatr Nurs. 2003; 15:28-32.
7. Methotrexate sodium for injection package insert. Florence, KY: Xanodyne Pharmacal, Inc.; 2003 Oct.
8. Kurnik D, Loebstein R, Fishbein E et al. Bioavailability of oral vs. subcutaneous low-dose methotrexate in patients with Crohn's disease. Aliment Pharmacol Ther. 2003; 18:57-63.
9. Schröder O, Stein J. Low dose methotrexate in inflammatory bowel disease: current status and future directions. Am J Gastroenterol. 2003; 98:530-7.
10. Siegel CA, Sands BE. Review article: practical management of inflammatory bowel disease patients taking immunomodulators. Aliment Pharmacol Ther. 2005; 22:1-16.
11. Bedford Laboratories. Methotrexate for injection: material safety data sheet. www.bedfordlabs.com/products/msdses/ Methotrexate-Lyo-8-23-05.pdf (accessed 2006 Jul 9).
12. Norfolk and Norwich University Hospital NHS Trust. Methotrexate shared care protocol-appendix 1: safety guidelines for administration of IM and SC methotrexate in the treatment of inflammatory bowel disease in the community via GP surgery. August 2003. www.nnuh.nhs. uk/doc%5Ctrustdocs5%5C134.pdf (accessed 2006 Jul 25).
13. U.S. Department of Labor, Occupational Safety & Health Administration. Section VI: Chapter 2. Controlling occupational exposure to hazardous drugs. OSHA technical manual. www.osha.gov/dts/ osta/otm/otm_toc.html (accessed 2006 Apr 12).